Insider Trading April 15, 2026 06:22 PM

CoreWeave CDO Trims Stake via Trust Sale, Converts Class B Shares to Class A

Brannin McBee sold roughly $2.54 million in Class A stock and converted additional shares as the company reports major partnerships and financings

By Priya Menon CRWV
CoreWeave CDO Trims Stake via Trust Sale, Converts Class B Shares to Class A
CRWV

CoreWeave Chief Development Officer Brannin McBee sold 17,514 shares of Class A common stock indirectly through trusts on April 13, 2026, generating $2,539,395 in proceeds. On the same day, McBee converted 22,915 Class B shares into Class A shares through trusts. The transactions coincide with a stock price of $118.69, a 191% rise over the past year, and a broader set of corporate developments including a $6 billion expansion with Jane Street and sizable convertible note offerings.

Key Points

  • Brannin McBee sold 17,514 Class A shares indirectly through the Canis Major 2025 GRAT and Canis Minor 2025 GRAT on April 13, 2026, for a total of $2,539,395.
  • On the same day McBee converted 22,915 Class B shares into Class A shares, also acquired indirectly through trusts, with no cash price listed for the conversion.
  • CoreWeave shares trade at $118.69, up 191% over the past year, amid deals including a $6 billion expansion with Jane Street and large convertible note issuances.

CoreWeave, Inc. (CRWV) reported an insider transaction in which Chief Development Officer Brannin McBee, acting indirectly through trusts, sold 17,514 shares of Class A common stock on April 13, 2026. The sales, disclosed in a Form 4 filing with the Securities and Exchange Commission, were executed at prices between $104.5389 and $113.7675, producing aggregate proceeds of $2,539,395.

The filing specifies that the disposals were made indirectly through two trusts named the Canis Major 2025 GRAT and the Canis Minor 2025 GRAT. On the same date, McBee also converted 22,915 shares of Class B common stock into Class A common stock. That conversion, likewise recorded as an indirect acquisition through trusts, listed no cash price for the conversion.

The insider activity takes place while CoreWeave shares trade at $118.69. The stock is up 191% over the last year. At the same time, valuation commentary included with reporting indicates the company appears overvalued relative to its Fair Value, trading at elevated revenue and EBITDA multiples despite not reporting profitability over the most recent twelve-month period.

In parallel with these insider transactions, CoreWeave has announced an expansion agreement with Jane Street valued at $6 billion. That arrangement includes access to CoreWeave's AI compute infrastructure and NVIDIA's Vera Rubin platform. As part of the Jane Street arrangement, Jane Street purchased $1 billion of CoreWeave Class A common stock at $109.00 per share.

CoreWeave has also completed two private debt offerings. The company issued $4 billion in Convertible Senior Notes due in 2032 and $1.75 million in Senior Notes due in 2031. According to the disclosures, those notes are convertible either into cash or into CoreWeave Class A common stock, with the conversion rate set at a 30% premium over a specified price.

Following the announced expansion and other corporate developments, several sell-side research actions were recorded. Evercore ISI raised its price target on CoreWeave to $150 and maintained an Outperform rating. Separately, Bernstein SocGen Group raised its price target to $67 while keeping an Underperform rating; that action followed the company’s announcements of new deals with Meta and Anthropic.

Taken together, the insider sale, the share conversion, the strategic expansion with Jane Street, and the large debt financings underscore a period of active capital and partnership activity at CoreWeave. The disclosure shows the specific mechanics of the insider transactions but does not offer additional commentary from company executives on the motives behind the moves or the precise terms referenced as the specified price for note conversions.

Risks

  • Valuation risk: Analysis indicates the stock appears overvalued relative to its Fair Value, trading at high revenue and EBITDA multiples while the company has not been profitable over the last twelve months - this affects equity investors and technology sector valuations.
  • Financing and conversion uncertainty: The company issued $4 billion in Convertible Senior Notes due 2032 and $1.75 million in Senior Notes due 2031 that are convertible into cash or stock at a 30% premium over a specified price, creating potential dilution or cash-conversion outcomes that could impact shareholders and credit markets.
  • Information limitation: The filing does not disclose detailed rationale for the insider sale or the specified price referenced for note conversions, leaving uncertainty about timing and strategic intent that affects investor interpretation.

More from Insider Trading

Charles Schwab Risk Chief Sells $4.08M in Stock, Exercises Equivalent Options Ahead of Earnings Apr 15, 2026 Airwa Director Adds to Stake as Company Completes $140M Acquisition Apr 15, 2026 Photronics Director Sells $225,000 in Stock After Exercising Options; Company Posts Quarterly Beat and Advances Mask Capability Apr 15, 2026 Genprex Director Disposes of Small Holding as Company Advances Gene Therapy IP and Data Presentations Apr 15, 2026 Arista CEO Jayshree Ullal Sells $16.9M in ANET Stock Under 10b5-1 Plan Apr 15, 2026